These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31111736)

  • 21. Clarifying the regulation of genome editing in Australia: situation for genetically modified organisms.
    Thygesen P
    Transgenic Res; 2019 Aug; 28(Suppl 2):151-159. PubMed ID: 31321698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically modified organisms: do the benefits outweigh the risks?
    Hug K
    Medicina (Kaunas); 2008; 44(2):87-99. PubMed ID: 18344661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Editing of Microalgae: Scientific Progress and Regulatory Challenges in Europe.
    Spicer A; Molnar A
    Biology (Basel); 2018 Mar; 7(1):. PubMed ID: 29509719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Making the EU "risk window" transparent: the normative foundations of the environmental risk assessment of GMOs.
    Jensen KK; Gamborg C; Madsen KH; Jørgensen RB; von Krauss MK; Folker AP; Sandøe P
    Environ Biosafety Res; 2003; 2(3):161-71. PubMed ID: 15612414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches in the risk assessment of genetically modified foods by the Hellenic Food Safety Authority.
    Varzakas TH; Chryssochoidis G; Argyropoulos D
    Food Chem Toxicol; 2007 Apr; 45(4):530-42. PubMed ID: 17275157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principles for the risk assessment of genetically modified microorganisms and their food products in the European Union.
    Aguilera J; Gomes AR; Olaru I
    Int J Food Microbiol; 2013 Oct; 167(1):2-7. PubMed ID: 23632210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of genetically modified organisms (GMOs) in the European Union: principles of risk assessment.
    Anadón A; Roda L; Martínez-Larrañaga MR
    Vet Hum Toxicol; 2004 Dec; 46(6):340-1. PubMed ID: 15587259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GM Risk Assessment.
    Sparrow PA
    Methods Mol Biol; 2009; 478():315-30. PubMed ID: 19009454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Governing GMOs in the USA: science, law and public health.
    Yang YT; Chen B
    J Sci Food Agric; 2016 Apr; 96(6):1851-5. PubMed ID: 26536836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GMO Genetic Elements Thesaurus (GMO-GET): a controlled vocabulary for the consensus designation of introduced or modified genetic elements in genetically modified organisms.
    Adamse P; Dagand E; Bohmert-Tatarev K; Wahler D; Miranda M; Kok EJ; Bendiek J
    BMC Bioinformatics; 2021 Feb; 22(1):48. PubMed ID: 33546585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Certain new plant breeding techniques and their marketability in the context of EU GMO legislation - recent developments.
    Zimny T; Sowa S; Tyczewska A; Twardowski T
    N Biotechnol; 2019 Jul; 51():49-56. PubMed ID: 30779963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the environmental fate of rAAV in activated sludge and water: Implications for environmental risk assessments and GMO regulatory frameworks.
    Fleischmann T
    J Environ Manage; 2023 Nov; 345():118754. PubMed ID: 37659367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and traceability of genetically modified organisms in the food production chain.
    Miraglia M; Berdal KG; Brera C; Corbisier P; Holst-Jensen A; Kok EJ; Marvin HJ; Schimmel H; Rentsch J; van Rie JP; Zagon J
    Food Chem Toxicol; 2004 Jul; 42(7):1157-80. PubMed ID: 15123385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory framework for genetically modified organisms in the Kingdom of Eswatini.
    Nkhabindze BZ; Magagula CN; Earnshaw D; Mhlanga CF; Matsebula SN; Dladla IG
    GM Crops Food; 2024 Dec; 15(1):212-221. PubMed ID: 38963885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.
    Baldo A; van den Akker E; Bergmans HE; Lim F; Pauwels K
    Curr Gene Ther; 2013 Dec; 13(6):385-94. PubMed ID: 24195604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creating conditions for the success of the French industrial advanced therapy sector.
    Lirsac PN; Blin O; Magalon J; ; Angot P; de Barbeyrac E; Bilbault P; Bourg E; Damour O; Faure P; Ferry N; Garbil B; Larghero J; Nguon M; Pattou F; Thumelin S; Yates F
    Therapie; 2015; 70(1):69-94. PubMed ID: 25747840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of new Brazilian legislation for the approval of advanced therapy medicinal products with existing systems in the USA, European Union and Japan.
    Gomes KLG; da Silva RE; da Silva Junior JB; Novaes MRCG
    Cytotherapy; 2022 May; 24(5):557-566. PubMed ID: 35227603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JRC GMO-Amplicons: a collection of nucleic acid sequences related to genetically modified organisms.
    Petrillo M; Angers-Loustau A; Henriksson P; Bonfini L; Patak A; Kreysa J
    Database (Oxford); 2015; 2015():. PubMed ID: 26424080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.